Home|
Cholesterol drug cancer warning Patients have been urged to keep taking a cholesterol-lowering treatment despite a study linking it to higher cancer risk. Home > Rss Directory > General > BBC |
|
Experts in drug 'ration' warning Top cancer specialists say NHS drug "rationing" is forcing cancer patients to remortgage homes to pay for treatment. Home > Rss Directory > General > BBC |
|
Cholesterol-Fighting Drugs Show Wider Benefit - New York Times BBC NewsCholesterol-Fighting Drugs Show Wider BenefitNew York Times - 2 hours agoBy PAM BELLUCK A large new study suggests that millions more people could benefit from taking the cholesterol-lowering drugs known as statins, even if they have low cholesterol, because the Home > Rss Directory > General > Google News |
|
Study Leads to Doctors' About-Face on Cholesterol Drug Doctors are stunned by the results of a study on Vytorin that show the cholesterol drug fails to improve heart disease even though it effectively reduces three key risk factors. Leading cardiologists are urging a return to older, tried-and-true treatments for cholesterol. Home > Rss Directory > Technology > Wired News |
|
Study Leads to Doctors' About-Face on Cholesterol Drug Doctors are stunned by the results of a study on Vytorin that show the cholesterol drug fails to improve heart disease even though it effectively reduces three key risk factors. Leading cardiologists are urging a return to older, tried-and-true treatments for cholesterol. Home > Rss Directory > General > Wired News |
|
Cholesterol as a Danger Has Skeptics - New York Times dBTechnoCholesterol as a Danger Has SkepticsNew York Times - 58 minutes agoBy ALEX BERENSON For decades, the theory that lowering cholesterol is always beneficial has been a core principle of cardiology. It has been accepted by doctors and used by drug makers to win qu Home > Rss Directory > General > Google News |
|
What That Cholesterol Trial Didn’t Show - New York Times New York TimesWhat That Cholesterol Trial Didn’t ShowNew York Times - 50 minutes agoBy TARA PARKER-POPE The cholesterol drug Vytorin became known for its commercials showing people who look oddly similar to foods like tacos and banana cream pie.How Vytorin F Home > Rss Directory > General > Google News |
|
Cell Phones & Cancer: A Controversial New Warning - InjuryBoard.com ABC NewsCell Phones & Cancer: A Controversial New WarningInjuryBoard.com - 56 minutes agoTalking less on your cell phone might save more than just minutes. For the first time, an academic cancer research institute has made a warning linking cancer and cell phone use. Home > Rss Directory > General > Google News |
|
Breast Cancer Drug Approved - Washington Post dBTechnoBreast Cancer Drug ApprovedWashington Post - Feb 23, 2008A drug to treat breast cancer received approval yesterday from the Food and Drug Administration, which went against the recommendation of its advisory panel.Genentech's Avastin wins OK to treat breast Home > Rss Directory > General > Google News |
|
UPDATE 1-Drug prevents bone loss in prostate cancer - Amgen - Reuters Ontario NowUPDATE 1-Drug prevents bone loss in prostate cancer - AmgenReuters - 3 hours agoBy Deena Beasley LOS ANGELES, July 14 (Reuters) - In a study, Amgen Inc's (AMGN.O: Quote, Profile, Research) experimental drug denosumab reduced the risk of osteoporosis and fract Home > Rss Directory > General > Google News |
|
UPDATE 1-J&J adds cancer warning to diabetic foot gel - Reuters eFluxMediaUPDATE 1-J&J adds cancer warning to diabetic foot gelReuters - 3 hours agoWASHINGTON, June 6 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile, Research) has added a strong "black box" warning about the risk of dying from cancer to the prescribing instructi Home > Rss Directory > General > Google News |
|
Genzyme Wins Cholesterol Drug Deal Genzyme has agreed to pay at least $325 million to win the hotly contested rights to a potentially powerful cholesterol-lowering drug. Home > Rss Directory > Business > NY Time |
|
Study Reveals Doubt on Drug for Cholesterol A clinical trial of Zetia, a widely used cholesterol drug, has raised questions about its effectiveness and the behavior of pharmaceutical companies that conducted the study. Home > Rss Directory > Business > NY Time |
|
Narcolepsy drug helps cancer-related fatigue: study - Reuters Canada.comNarcolepsy drug helps cancer-related fatigue: studyReuters - 1 hour agoCHICAGO (Reuters) - The narcolepsy drug Provigil can alleviate severe cancer-related fatigue, according to new research presented on Saturday at a meeting of the American Society for Clinic Home > Rss Directory > General > Google News |
|
Study: Wider Cholesterol Drug Use May Save Lives Cholesterol drug Crestor cuts deaths, heart attacks in healthy people; could see wider use Home > Rss Directory > General > ABC News |
|
AstraZeneca's Cholesterol Win - Forbes That Happened!AstraZeneca's Cholesterol WinForbes - 3 hours agoScore one for Crestor. AstraZeneca's cholesterol drug has just been through a giant, 18000-patient study and the results are dramatic.An extreme makeover of your arteries Houston ChronicleAstraZeneca Home > Rss Directory > General > Google News |
|
Health Buzz: Immunosuppressive Drug Warning and Other Health News - U.S. News & World Report dBTechnoHealth Buzz: Immunosuppressive Drug Warning and Other Health NewsU.S. News & World Report - 7 hours agoThe Food and Drug Administration has asked the manufacturers of Humira, Cimzia, Enbrel, and Remicade—which belong to a class of medications known as tumor ne Home > Rss Directory > General > Google News |
|
What That Cholesterol Trial Didn’t Show The cholesterol drug Vytorin became known for its commercials showing people who look oddly similar to foods like tacos and banana cream pie. But now Vytorin is getting attention that is anything but funny. Home > Rss Directory > General > NY Time |
|
Doctors Wary After Cholesterol Drug Flop Doctors Leery of Cholesterol Drugs Vytorin, Zetia After Key Study Flops Home > Rss Directory > General > ABC News |
|
FDA Breast Cancer Drug Approval Prompts Mixed Reaction In a surprise decision that could represent a shift in standards for assessing the effectiveness of cancer medicines, the FDA clears Avastin for use in treating breast cancer. The federal agency is judging the drug's effectiveness based on measurements of tumor growth, not patient survival. Home > Rss Directory > General > Wired News |